Chlamydiosis

Chlamydiosis, also known as psittacosis or parrot fever, is a significant bacterial infection caused by the obligate intracellular organism Chlamydia psittaci. This zoonotic disease affects a wide range of bird species but holds particular importance in Amazon parrots and other psittacines due to their popularity as companion birds and their ability to transmit the infection to humans. Chlamydiosis can range from subclinical infection, where birds carry and shed the organism without showing obvious illness, to severe systemic disease with life-threatening complications. The zoonotic potential of this infection makes it a reportable disease in many jurisdictions, elevating its significance beyond typical avian health concerns.

The causative agent, Chlamydia psittaci, behaves unlike typical bacteria in many respects. As an obligate intracellular pathogen, it can only reproduce inside host cells, where it hijacks cellular machinery for its survival and replication. The organism exists in two forms: the elementary body, which survives in the environment and initiates new infections, and the reticulate body, which replicates inside host cells. This dual existence allows Chlamydia psittaci to persist in the environment for extended periods and to evade certain aspects of the host immune response. Birds can become chronically infected, shedding organisms intermittently for months to years even without showing clinical signs.

The impact of chlamydiosis on affected Amazon parrots varies considerably depending on the strain of organism, the bird's immune status, and environmental factors. Acute infections can cause severe respiratory distress, hepatic damage, and death within days if untreated. Chronic infections may cause vague, intermittent symptoms that wax and wane over extended periods. Stress frequently triggers shedding and clinical disease in chronically infected birds, meaning a previously healthy-appearing bird may suddenly become ill when moved, housed with new birds, or experiencing other stressors. The immunosuppressive effects of the infection can predispose birds to secondary infections and other health problems.

Treatment for chlamydiosis is available and effective when initiated appropriately, making early diagnosis crucial for favorable outcomes. Antibiotic therapy, typically with doxycycline or other tetracyclines, must be administered for extended periods to eliminate the intracellular organism. Supportive care addresses symptoms while antibiotics work against the infection. The zoonotic nature of chlamydiosis adds urgency to treatment and requires precautions to protect human family members during the treatment period. With appropriate therapy, most birds with chlamydiosis can recover fully, though some may require repeated treatment or become chronic carriers despite intervention.

The primary cause of chlamydiosis is infection with Chlamydia psittaci, a gram-negative obligate intracellular bacterium. Transmission occurs through inhalation of aerosolized particles from dried feces, respiratory secretions, or feather dust from infected birds. Direct contact with infected birds or their secretions provides another transmission route. The organism remains viable in dried feces and secretions for weeks to months, allowing environmental contamination to serve as an ongoing infection source. Vertical transmission from infected hen to egg has been documented, meaning chicks can be born with the infection. The infectious dose is relatively low, making exposure to even small amounts of contaminated material potentially dangerous.

While Chlamydia psittaci does not have genetic components affecting susceptibility, certain factors determine which birds become infected and develop clinical disease. Young birds and those with immature or compromised immune systems face higher risk of severe disease when exposed. Birds experiencing stress from any cause, including environmental changes, breeding, molting, or concurrent illness, are more susceptible to infection and to clinical manifestation if already carrying the organism. Overcrowded conditions facilitate transmission and increase stress, compounding infection risk. Previous exposure may provide some immunity, but protection is not absolute and reinfection can occur.

Environmental and husbandry factors significantly influence chlamydiosis transmission and disease expression in captive bird populations. Poor ventilation allows infectious particles to accumulate in enclosed spaces, increasing exposure for all birds in the environment. Inadequate cleaning and disinfection protocols permit environmental persistence of the organism. Mixing birds from different sources without quarantine spreads infection between previously separate populations. Stress from inappropriate housing, diet, or social situations increases susceptibility to disease. Breeding facilities and pet stores with high bird turnover face particularly elevated risk for chlamydiosis circulation.

Risk factors for chlamydiosis acquisition and disease development include several identifiable categories. Birds imported from regions with high disease prevalence carry elevated risk. Newly acquired birds from any source represent potential infection introduction. Young birds, particularly those recently weaned, are more susceptible to clinical disease. Immunocompromised individuals, whether from concurrent illness, malnutrition, or other factors, face greater risk of severe disease. Contact with wild birds or their droppings presents exposure opportunity. Attendance at bird shows, fairs, or other gatherings where multiple bird sources mix increases transmission risk substantially.

The mechanism of chlamydiosis development involves a complex interaction between the organism's unique biology and host immune response. Following inhalation, Chlamydia psittaci elementary bodies attach to and enter respiratory epithelial cells. Inside cells, elementary bodies transform into metabolically active reticulate bodies that replicate, producing progeny. After replication, reticulate bodies convert back to elementary bodies, which are released when the host cell ruptures, infecting neighboring cells and continuing the cycle. The organism spreads systemically through the bloodstream, reaching the liver, spleen, and other organs. Host immune response controls but may not eliminate infection, leading to the chronic carrier state characteristic of many cases.

Early warning signs of chlamydiosis in Amazon parrots can be subtle and easily missed, particularly since birds instinctively hide illness to avoid appearing vulnerable. Initial indicators may include mild decrease in activity or appetite that the owner might attribute to normal variation. Slight changes in droppings, including increased urates or mild color changes, may precede more obvious symptoms. Subtle respiratory signs like occasional sneezing or slight increase in breathing effort during activity might be noticed. Feather quality may decrease slightly, with less attention to preening. These early signs typically develop over days to weeks and may fluctuate, with the bird appearing better on some days than others.

Common symptoms of established chlamydiosis become more apparent as the infection progresses and involves multiple organ systems. Respiratory symptoms frequently predominate, including nasal discharge, sneezing, labored breathing, and tail bobbing with respiration. Ocular symptoms including conjunctivitis with swollen, reddened eyes and discharge often develop. Lethargy becomes pronounced, with affected birds spending more time sleeping and less time engaged in normal activities. Decreased appetite leads to weight loss, sometimes dramatic. Diarrhea develops as gastrointestinal involvement progresses. Droppings often show characteristic changes including bright green color from biliverdin due to liver involvement and increased urates. Fluffed feathers and decreased preening reflect the bird's overall poor condition.

Behavioral changes associated with chlamydiosis provide important diagnostic clues that observant owners and clinicians should recognize. Affected birds become progressively more withdrawn, spending less time interacting with owners or cage mates. Vocalization typically decreases, with normally talkative Amazon parrots becoming quiet. Appetite changes may include refusing favorite foods or decreased interest in eating. Sleep patterns change, with increased daytime sleeping. Irritability may develop, with previously friendly birds becoming less tolerant of handling. Some birds may show unusual behaviors like sitting on the cage floor rather than perching. These behavioral changes reflect the systemic nature of the infection and the bird's overall malaise.

Physical signs visible on examination reveal the extent of systemic involvement in clinical chlamydiosis. Respiratory findings include nasal discharge that may be clear, mucoid, or purulent, along with increased respiratory rate and effort. Ocular examination reveals conjunctival inflammation and discharge in many cases. The bird may appear thin with prominent keel bone due to muscle wasting. Feather condition deteriorates, with broken, dirty, or unkempt appearance. Droppings in the cage show the characteristic changes described earlier. Hepatomegaly and splenomegaly may be detectable on physical examination in advanced cases. Neurological signs including head tilts, tremors, or ataxia occasionally develop when central nervous system involvement occurs.

Symptom progression in untreated chlamydiosis typically follows an increasingly severe course that can become life-threatening. Early vague symptoms evolve into obvious respiratory distress with open-mouth breathing. Weight loss becomes severe as appetite fails and metabolic demands from fighting infection increase. Secondary bacterial infections may develop in compromised respiratory or gastrointestinal tissues, further complicating the clinical picture. Liver failure can develop in severe cases, causing coagulation problems and additional metabolic derangement. Without treatment, death can occur within days to weeks depending on infection severity and the bird's baseline health status.

Emergency symptoms requiring immediate avian veterinary attention include severe respiratory distress manifesting as open-mouth breathing, marked tail bobbing, and obvious struggling. Collapse or extreme weakness indicates life-threatening compromise. Bleeding from any location may signal liver failure and coagulation defects. Neurological signs including seizures, severe ataxia, or loss of consciousness require urgent evaluation. Any bird showing signs of shock including extreme weakness and pallor needs emergency stabilization. Additionally, because chlamydiosis is zoonotic, any bird suspected of having the disease should be evaluated promptly to protect human family members from infection.

Initial veterinary examination for suspected chlamydiosis involves comprehensive assessment of the bird's condition along with detailed history taking. The avian veterinarian conducts thorough physical examination, evaluating respiratory effort, auscultating for abnormal lung sounds, and checking for ocular and nasal discharge. Hepatosplenomegaly may be detected on palpation in some cases. The veterinarian assesses hydration status, body condition, and overall degree of illness. History review includes questions about other birds in the household, recent acquisitions or exposures, attendance at bird shows or other events, and any illness in human family members. Because chlamydiosis is zoonotic and often reportable, the veterinarian may also gather information needed for public health notification.

Diagnostic testing for chlamydiosis utilizes multiple modalities to confirm infection and assess its systemic effects. Blood work including complete blood count often reveals heterophilia and monocytosis characteristic of this infection. Chemistry panel may show elevated liver enzymes and biliverdin, reflecting hepatic involvement. Radiographs visualize hepatomegaly and splenomegaly and may reveal pulmonary changes. Specific testing for Chlamydia psittaci includes PCR testing on samples from the choana, conjunctiva, and cloaca, which detects organism DNA. Serology detects antibodies against the organism, though interpretation requires understanding of vaccination status and previous exposure. Culture of the organism is definitive but technically demanding and potentially hazardous to laboratory personnel. Combination of testing modalities provides the most accurate diagnosis.

Differential diagnosis for chlamydiosis considers other conditions causing similar respiratory and systemic symptoms. Other bacterial respiratory infections, including those caused by gram-negative organisms, can present similarly. Viral diseases including polyomavirus, avian borna virus, and paramyxovirus produce overlapping symptoms. Fungal infections, particularly aspergillosis, cause respiratory signs that may mimic chlamydiosis. Mycoplasma infections produce respiratory disease requiring similar evaluation. Non-infectious causes of respiratory symptoms including air sac problems and cardiac disease must be considered. The systemic nature of chlamydiosis, affecting multiple organs simultaneously, helps differentiate it from more localized infections.

Diagnosis confirmation for chlamydiosis relies on positive detection of Chlamydia psittaci by PCR or other specific testing, often combined with supportive clinical and laboratory findings. False-negative results can occur, particularly if the bird is shedding intermittently or if sampling technique is suboptimal. Because of this, strong clinical suspicion with compatible symptoms and exposure history may justify treatment even without definitive test confirmation in some cases. Once diagnosis is established, public health authorities may need to be notified depending on local reporting requirements. The veterinarian discusses findings with the owner, including implications for other birds in the household, zoonotic risk, and the comprehensive treatment plan.

Emergency and immediate treatment for Amazon parrots presenting with severe chlamydiosis focuses on stabilization before definitive therapy. Birds in respiratory distress require oxygen supplementation and placement in a warm, quiet, humidified environment to ease breathing. Fluid therapy addresses dehydration and supports organ function. Nutritional support may be needed if the bird is not eating, sometimes requiring assisted feeding or hospitalization for gavage. Nebulization with saline and sometimes antibiotics helps mobilize respiratory secretions. Pain management and stress reduction support the bird's overall recovery. Concurrent supportive medications may address specific symptoms. Hospitalization is often required for severely ill birds until stabilization allows transition to outpatient management.

Medical management of chlamydiosis centers on extended antibiotic therapy to eliminate the intracellular organism. Doxycycline is the treatment of choice, though administration route varies by situation. Oral doxycycline suspension, given daily for 45 days, is commonly used for stable outpatients. Doxycycline-medicated water or food provides alternatives for birds difficult to medicate directly, though achieving consistent dosing can be challenging. Injectable doxycycline formulations provide another option, with some long-acting preparations reducing injection frequency. Other tetracyclines may be substituted when doxycycline is not available or tolerated. The extended treatment duration, typically 45 days minimum, is essential because the organism's intracellular location protects it from shorter antibiotic courses. Premature discontinuation risks relapse and development of chronic carrier status.

Surgical intervention is not typically part of chlamydiosis treatment, as the infection responds to medical management. However, complications occasionally require procedural intervention. Severely impacted sinuses may require surgical drainage. Air sacculitis developing as a complication might require therapeutic lavage. Abscesses forming at sites of severe infection occasionally need surgical attention. These interventions remain uncommon in chlamydiosis management, with the vast majority of cases responding to medical therapy alone. Veterinarians address complications as they arise within the context of overall medical management.

Supportive care measures complement antibiotic therapy throughout the treatment period. Nutritional support ensures the bird receives adequate calories and nutrients for immune function and healing. Vitamin A supplementation may support respiratory epithelial health. Heat supplementation maintains appropriate body temperature, reducing metabolic demands. Humidity in the environment eases breathing when respiratory symptoms are present. Stress reduction through quiet housing and limited handling supports recovery. Environmental cleaning and disinfection reduce reinfection risk from contaminated surfaces. Isolation from other birds prevents transmission during the infectious period. Regular monitoring assesses treatment response and identifies any developing complications.

Alternative and complementary treatments may support recovery from chlamydiosis as adjuncts to essential antibiotic therapy. Nebulization with saline or mucolytic agents helps clear respiratory secretions. Immune-supporting supplements may help the bird fight infection, though they do not replace appropriate antibiotics. Probiotics may support gastrointestinal health during extended antibiotic therapy. Herbal preparations with antimicrobial or immune-modulating properties are sometimes suggested, though evidence for effectiveness is limited. Stress-reduction approaches including appropriate environmental enrichment support overall recovery. These complementary approaches should never substitute for appropriate antibiotic therapy but may enhance recovery when integrated into comprehensive care.

Treatment decision-making for chlamydiosis considers the medical requirements of the infection along with practical and public health factors. The zoonotic nature of the infection adds urgency to treatment initiation and may influence quarantine decisions. Treatment duration of 45 days requires owner commitment to daily medication administration, influencing how therapy is structured. Cost considerations include not only treatment but potentially extended monitoring and testing. Household implications, including other birds that may need testing or treatment and risk to human family members, factor into planning. Expected outcomes are generally favorable with appropriate treatment, though some birds become chronic carriers despite therapy. Quality of life during treatment, including managing the stress of daily medication, influences how therapy is optimized.

Recovery timeline for Amazon parrots with chlamydiosis varies based on initial disease severity and treatment response. Clinical improvement often becomes apparent within the first week of appropriate antibiotic therapy, with respiratory symptoms and appetite beginning to improve. Substantial improvement typically occurs by two to three weeks into treatment, though some symptoms may persist longer. Complete clinical recovery is expected by the end of the 45-day treatment course in most cases. However, treatment must continue for the full duration regardless of clinical improvement to achieve organism elimination. Post-treatment testing, typically two weeks after completing antibiotics, confirms successful treatment or identifies cases requiring additional therapy.

Post-treatment care requirements focus on ensuring treatment completion and confirming successful organism elimination. Medication administration must continue reliably for the entire prescribed duration, even after the bird appears recovered. Follow-up appointments during treatment allow monitoring of progress and early detection of any problems. Post-treatment testing typically includes repeat PCR testing from multiple sites to confirm the organism has been eliminated. Some veterinarians recommend multiple negative tests before declaring treatment success. Gradual reintroduction to other household birds occurs only after confirmed negative testing. Environmental thorough cleaning and disinfection remove organisms that might cause reinfection.

Prognosis for chlamydiosis is generally favorable when appropriate treatment is initiated before severe organ damage occurs. Most birds with acute chlamydiosis treated appropriately make full clinical recoveries. Some birds become chronic carriers despite treatment, requiring additional therapy or posing ongoing transmission risk. Birds with severe hepatic or respiratory damage at presentation may have more guarded prognosis, though many still recover. Treatment failure or relapse occurs in a minority of cases, usually responding to retreatment with the same or alternative antibiotics. Factors affecting prognosis include duration and severity of illness before treatment, overall health status, and completeness of treatment course.

Long-term outlook for birds recovered from chlamydiosis is generally excellent for clinical health, though some considerations persist. Reinfection is possible following exposure to infected birds, so prevention remains important. Some birds may become chronic shedders despite treatment, requiring ongoing monitoring and precautions. Immunity following infection is not absolute or permanent. Regular veterinary monitoring helps detect any recurrence early. For most recovered birds, normal lifespan and quality of life can be expected. The main long-term consideration is preventing reinfection through appropriate biosecurity measures and avoiding exposure to untested birds.

Environmental prevention strategies for chlamydiosis focus on minimizing exposure to the organism and maintaining conditions that reduce transmission risk. Excellent ventilation prevents accumulation of infectious particles in enclosed spaces. Regular, thorough cleaning removes organic material that might harbor organisms. Appropriate disinfection with products effective against Chlamydia psittaci, including quaternary ammonium compounds and oxidizing agents, eliminates environmental contamination. Air filtration may reduce airborne particle concentration in high-risk environments. Preventing exposure to wild bird droppings removes an environmental source of potential infection. Avoiding overcrowding reduces both stress and transmission opportunity.

Quarantine protocols represent the single most important prevention measure for chlamydiosis in companion bird households and breeding facilities. All newly acquired birds should be quarantined for a minimum of 30 to 45 days, ideally with testing for Chlamydia psittaci before joining resident birds. Quarantine housing should be in a separate airspace from resident birds, ideally a different building. Caretakers should attend to quarantined birds after caring for resident birds and should change clothes and wash hands between populations. Testing during quarantine, preferably repeated at the beginning and end of the quarantine period, identifies infected birds before they can transmit to others. Birds from high-risk sources including bird shows, imports, and rescue situations warrant particularly stringent quarantine.

Dietary prevention, while not directly preventing infection, supports immune function that helps birds resist and clear infections. Adequate vitamin A is particularly important for maintaining healthy respiratory epithelium that serves as the first line of defense against infection. High-quality, balanced nutrition supports overall immune competence. Avoiding malnutrition ensures birds can mount effective immune responses when exposed to pathogens. Fresh foods including vegetables provide antioxidants that support immune function. Proper diet reduces stress that predisposes to clinical disease in exposed birds.

Health maintenance through regular avian veterinary care provides opportunities for screening and early problem detection. Annual wellness examinations allow veterinarians to assess overall health and discuss biosecurity practices. Testing for chlamydiosis may be recommended for birds from higher-risk backgrounds or those with compatible symptoms. Addressing concurrent health problems reduces stress and immunocompromise that predispose to clinical disease. Building a relationship with an avian veterinarian enables rapid access to testing and treatment when exposure is suspected. Staying current on chlamydiosis developments helps owners understand evolving recommendations.

Early intervention when exposure or infection is suspected offers the best opportunity to prevent disease spread and complications. Any new bird should be tested before introduction regardless of apparent health status. Birds showing compatible symptoms should be isolated and evaluated promptly. Exposure to known-positive birds warrants testing and potentially prophylactic treatment. Prompt diagnosis and treatment of infected birds prevents transmission to other birds and to human family members. Because chlamydiosis is zoonotic, early intervention also protects human health. Aggressive biosecurity response when infection is identified in a collection can prevent widespread outbreak.

Daily management during chlamydiosis treatment requires consistent attention to medication administration and monitoring. Antibiotics must be given reliably at the same time each day for the entire 45-day treatment period. Owners should observe the bird daily for signs of improvement or any concerning developments. Appetite, droppings, breathing, and activity level should all be monitored. Weight should be checked regularly, ideally daily or every few days, to ensure the bird is maintaining or gaining weight during recovery. Environmental cleaning should be enhanced during the treatment period to reduce organism load in the bird's surroundings. A simple daily log of observations helps track progress and provides valuable information for veterinary appointments.

Home environment modifications during treatment and recovery focus on reducing stress and supporting healing while minimizing transmission risk. The infected bird should be isolated from other birds to prevent transmission. The room housing the infected bird should have good ventilation but should not share air handling with areas housing other birds. Temperature should be maintained in the warmer end of the appropriate range to reduce metabolic demands. Humidity may help ease respiratory symptoms. Cleaning should be thorough and frequent, with careful attention to disinfection. Caregivers should wear masks and practice good hand hygiene when handling the bird or cleaning its enclosure to reduce zoonotic risk.

Maintaining quality of life during the treatment period requires balancing isolation requirements with the social needs of these highly intelligent birds. Social interaction with the caregiver, using appropriate precautions, should continue during treatment. Mental stimulation through foraging opportunities, toys, and enrichment helps maintain psychological health during the recovery period. Comfortable perching and easy access to food and water reduce stress. Favorite foods, if the bird is eating, provide both nutrition and positive experiences. Keeping the environment calm and predictable reduces stress that could impair recovery. The goal is to support healing while keeping the bird as comfortable and content as possible.

Ongoing monitoring and veterinary follow-up remain essential throughout treatment and afterward. Scheduled rechecks during treatment allow assessment of clinical progress and adjustment of supportive care as needed. Post-treatment testing confirms successful organism elimination. Signs that warrant earlier veterinary contact include any worsening of symptoms, complete refusal to eat, extreme lethargy, or new symptoms developing during treatment. Medication problems including suspected reactions should be reported promptly. After confirmed recovery, ongoing awareness of recurrence potential informs continued monitoring.

Caregiver support acknowledges the challenges of managing a zoonotic infection in a beloved pet. Understanding the actual zoonotic risk helps owners take appropriate precautions without excessive fear. Resources for managing medication administration help ensure treatment compliance. Connecting with other owners who have navigated chlamydiosis provides practical advice and emotional support. Financial planning for the extended treatment course and monitoring reduces stress. Support in managing household implications, including protecting other birds and human family members, helps owners navigate the situation effectively. Caring for a bird through chlamydiosis treatment is demanding but rewarding when it leads to full recovery.

While Chlamydia psittaci can infect virtually any bird species, certain groups demonstrate higher prevalence and susceptibility. Among psittacines, Amazon parrots, cockatiels, and budgerigars frequently appear in chlamydiosis case reports, likely reflecting their popularity as pets combined with genuine susceptibility. African Grey Parrots, macaws, and cockatoos also commonly develop the disease. Imported birds historically showed very high infection rates, though improved import regulations have reduced this concern. Birds from high-turnover environments including pet stores, bird shows, and large breeding operations face elevated exposure risk. Young birds, particularly recently weaned juveniles, often show more severe clinical disease when infected.

Beyond psittacines, other bird groups demonstrate chlamydiosis susceptibility. Pigeons and doves are commonly infected and serve as significant reservoirs for the organism in urban environments. Poultry species including turkeys and ducks can be infected, with outbreaks occurring in agricultural settings. Wild birds across numerous families can carry Chlamydia psittaci, potentially serving as infection sources for captive birds. Passerine species including finches and canaries can be infected, though clinical disease may be less common than in psittacines. The broad host range of Chlamydia psittaci means any bird species should be considered potentially susceptible.

Screening recommendations for at-risk birds aim to identify infection before transmission occurs. All newly acquired psittacines should be tested during quarantine, regardless of apparent health. Birds from high-risk sources including imports, rescues, and large-scale breeding operations warrant particularly thorough testing. Testing should include PCR from multiple sites, ideally choanal and cloacal swabs at minimum, repeated at the beginning and end of quarantine. Birds with any respiratory or systemic symptoms compatible with chlamydiosis should be tested promptly. Periodic screening of established collections may be warranted in higher-risk situations. Working with reputable breeders who test their birds and maintain closed flocks reduces acquisition risk.

Several conditions commonly co-occur with chlamydiosis or develop as complications of the infection. Secondary bacterial infections frequently develop when chlamydiosis damages respiratory or gastrointestinal tissues, providing opportunity for opportunistic pathogens. Concurrent viral infections may be present, particularly in birds from high-risk environments where multiple pathogens circulate. Hepatic disease may persist after the primary infection is treated, requiring ongoing management. Immunosuppression from chlamydiosis can allow other latent infections to emerge. Aspergillosis can develop in respiratory tissues damaged by chlamydiosis. Managing these concurrent conditions requires addressing both the primary chlamydiosis and any secondary problems.

Conditions with similar symptoms require differentiation from chlamydiosis for appropriate treatment. Other bacterial respiratory infections, including those caused by Mycoplasma, Pasteurella, and gram-negative organisms, produce similar symptoms. Aspergillosis and other fungal infections cause respiratory signs that may mimic chlamydiosis. Viral diseases including avian borna virus and polyomavirus can cause multisystemic signs. Proventricular dilatation disease produces some overlapping symptoms. Air sac disorders of various etiologies cause respiratory compromise. Accurate diagnosis matters significantly because treatment approaches differ, and failure to identify chlamydiosis has both patient care and public health implications.

Potential complications of chlamydiosis can significantly impact recovery and long-term prognosis. Chronic carrier status develops in some birds despite treatment, posing ongoing transmission risk. Persistent hepatic damage may require ongoing monitoring or management. Chronic respiratory compromise can result from severe acute infection. Air sacculitis may become chronic or recurrent. Secondary infections established during the primary illness may require additional treatment. Reproductive problems can occur in breeding birds. Zoonotic transmission to human contacts represents a serious complication requiring medical attention. Recognizing these potential complications helps guide monitoring and intervention.